233 related articles for article (PubMed ID: 21470421)
1. Identification of SERPINA1 as single marker for papillary thyroid carcinoma through microarray meta analysis and quantification of its discriminatory power in independent validation.
Vierlinger K; Mansfeld MH; Koperek O; Nöhammer C; Kaserer K; Leisch F
BMC Med Genomics; 2011 Apr; 4():30. PubMed ID: 21470421
[TBL] [Abstract][Full Text] [Related]
2. High Diagnostic Accuracy Based on CLDN10, HMGA2, and LAMB3 Transcripts in Papillary Thyroid Carcinoma.
Barros-Filho MC; Marchi FA; Pinto CA; Rogatto SR; Kowalski LP
J Clin Endocrinol Metab; 2015 Jun; 100(6):E890-9. PubMed ID: 25867809
[TBL] [Abstract][Full Text] [Related]
3. Identification of
Zhang Y; Xie X; Zhou H; Li B; Ding L; Cai Z; Song H; Zhao S; Xu H
Front Endocrinol (Lausanne); 2023; 14():1131078. PubMed ID: 37455914
[TBL] [Abstract][Full Text] [Related]
4. Network-based meta-analysis in the identification of biomarkers for papillary thyroid cancer.
Zhao H; Li H
Gene; 2018 Jun; 661():160-168. PubMed ID: 29625265
[TBL] [Abstract][Full Text] [Related]
5. A Set of Markers Related to Viral Infection Has a Sex-sensitive Prognostic Value in Papillary Thyroid Carcinoma.
Wan D; Yang X; Li G; Du Y; Cao J; Gao Y; Shu Z; Zhou Y; Wei X; Guo R; Zhang R; Zhang G
J Clin Endocrinol Metab; 2021 Apr; 106(5):e2334-e2346. PubMed ID: 33395461
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas.
Dettmer M; Vogetseder A; Durso MB; Moch H; Komminoth P; Perren A; Nikiforov YE; Nikiforova MN
J Clin Endocrinol Metab; 2013 Jan; 98(1):E1-7. PubMed ID: 23150679
[TBL] [Abstract][Full Text] [Related]
7. Identification of potential biomarkers and drugs for papillary thyroid cancer based on gene expression profile analysis.
Qu T; Li YP; Li XH; Chen Y
Mol Med Rep; 2016 Dec; 14(6):5041-5048. PubMed ID: 27779685
[TBL] [Abstract][Full Text] [Related]
8. Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma.
Li M; Song Q; Li H; Lou Y; Wang L
PLoS One; 2015; 10(7):e0132403. PubMed ID: 26168287
[TBL] [Abstract][Full Text] [Related]
9. Identification of Serpin peptidase inhibitor clade A member 1 (SERPINA1) might be a poor prognosis biomarker promoting the progression of papillary thyroid cancer.
Li Q; Dong X; Jin G; Dong Y; Yu Y; Jin C; Huang X
Life Sci; 2023 Sep; 329():121938. PubMed ID: 37487942
[TBL] [Abstract][Full Text] [Related]
10. ZCCHC12, a potential molecular marker of papillary thyroid carcinoma: a preliminary study.
Li QL; Chen FJ; Lai R; Guo ZM; Luo R; Yang AK
Med Oncol; 2012 Sep; 29(3):1409-17. PubMed ID: 21739307
[TBL] [Abstract][Full Text] [Related]
11. Meta- and reanalysis of gene expression profiles of hot and cold thyroid nodules and papillary thyroid carcinoma for gene groups.
Eszlinger M; Wiench M; Jarzab B; Krohn K; Beck M; Läuter J; Gubała E; Fujarewicz K; Swierniak A; Paschke R
J Clin Endocrinol Metab; 2006 May; 91(5):1934-42. PubMed ID: 16407496
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling identifies platelet-derived growth factor as a diagnostic molecular marker for papillary thyroid carcinoma.
Yano Y; Uematsu N; Yashiro T; Hara H; Ueno E; Miwa M; Tsujimoto G; Aiyoshi Y; Uchida K
Clin Cancer Res; 2004 Mar; 10(6):2035-43. PubMed ID: 15041723
[TBL] [Abstract][Full Text] [Related]
13. Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules.
Yu S; Liu X; Zhang Y; Li J; Chen S; Zheng H; Reng R; Zhang C; Chen J; Chen L
Oncotarget; 2016 Dec; 7(51):84165-84177. PubMed ID: 27705935
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA signature in thyroid fine needle aspiration cytology applied to "atypia of undetermined significance" cases.
Shen R; Liyanarachchi S; Li W; Wakely PE; Saji M; Huang J; Nagy R; Farrell T; Ringel MD; de la Chapelle A; Kloos RT; He H
Thyroid; 2012 Jan; 22(1):9-16. PubMed ID: 22136206
[TBL] [Abstract][Full Text] [Related]
15. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
16. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.
Iancu IV; Botezatu A; Plesa A; Huica I; Fudulu A; Albulescu A; Bostan M; Mihaila M; Grancea C; Manda DA; Dobrescu R; Vladoiu SV; Anton G; Badiu CV
Cancer Biomark; 2020; 28(2):255-268. PubMed ID: 32390600
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications.
Jarzab B; Wiench M; Fujarewicz K; Simek K; Jarzab M; Oczko-Wojciechowska M; Wloch J; Czarniecka A; Chmielik E; Lange D; Pawlaczek A; Szpak S; Gubala E; Swierniak A
Cancer Res; 2005 Feb; 65(4):1587-97. PubMed ID: 15735049
[TBL] [Abstract][Full Text] [Related]
18. Differences in Gene Expression Profile of Primary Tumors in Metastatic and Non-Metastatic Papillary Thyroid Carcinoma-Do They Exist?
Szpak-Ulczok S; Pfeifer A; Rusinek D; Oczko-Wojciechowska M; Kowalska M; Tyszkiewicz T; Cieslicka M; Handkiewicz-Junak D; Fujarewicz K; Lange D; Chmielik E; Zembala-Nozynska E; Student S; Kotecka-Blicharz A; Kluczewska-Galka A; Jarzab B; Czarniecka A; Jarzab M; Krajewska J
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32610693
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel long non-coding RNA biomarkers for prognosis prediction of papillary thyroid cancer.
Li Q; Li H; Zhang L; Zhang C; Yan W; Wang C
Oncotarget; 2017 Jul; 8(28):46136-46144. PubMed ID: 28545026
[TBL] [Abstract][Full Text] [Related]
20. Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules.
Finley DJ; Arora N; Zhu B; Gallagher L; Fahey TJ
J Clin Endocrinol Metab; 2004 Jul; 89(7):3214-23. PubMed ID: 15240595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
